NovaBay Pharmaceuticals , AME: NBY
A biopharmaceutical company focused on products to prevent a wide range of infections.
Industry: Health Care
First Day Return: -9.5%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 02/14/2007 |
| Offer Price | $4.00 |
| Price Range $4.00 - $6.00 | |
| Offer Shares (mm) | 5.0 |
| Deal Size ($mm) | $20 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 10/25/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $20 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Emeryville, CA, United States |
| Founded | 2000 |
| Employees at IPO | n/a |
NovaBay Pharmaceuticals (NBY) Performance
